|
As your industry comes of age, biotech companies around the world face unprecedented challenges, including regulation, pricing pressures, access to capital, acquisitions, and alliances.
Our 20 years of service to the biotechnology industry gives us the knowledge and perspective to help companies address these challenges. Worldwide, our professionals assist biotech executives and their boards by providing assurance, risk, tax, transaction, and finance-related services. Our involvement with, and dedication to, the industry is further enriched by our annual publication "Beyond Borders" and the Ernst & Young Global Biotechnology Center, where we connect our global network of professionals to help them deliver seamless, consistent, high-quality service.
|
